AI AND DATA STRATEGY · PHARMA, BIOTECH, HEALTH TECH

Understand what’s possible.Deliver what matters.

For 15+ years, I’ve used science, data, and AI to build capabilities that lead to faster, higher-confidence decisions in pharma, biotech, and health tech. I bring experience from large pharma, a data and AI partner to drug makers, hospital patient care, radiopharmaceutical manufacturing, and advisory work for investors.

Start a conversation
Nicholas Iannotti
Nicholas Iannotti, Ph.D. LinkedIn
CAREER
  • Pfizer
  • Novartis
  • AstraZeneca
  • ConcertAI
  • Ronin
  • Nucleus RadioPharma

Capabilities

AI Strategy & Governance

Roadmaps, business cases, and the investment process that decides what gets funded.

Designed and ran the Clearinghouse, AstraZeneca’s weekly AI investment committee across all therapeutic areas, with KPI and ROI requirements and staged go/no-go decisions.

AstraZeneca

AI in Production

Models, generative systems, and agents running in regulated, real-world settings.

Directed the design of agents and a generative AI stack that went live in patient care at MD Anderson Cancer Center, after every output passed purpose-built evaluators and expert review.

Ronin

Data Products & Partnerships

Real-world data products, licensing, and pharma partnerships at scale.

Scaled partnerships with 18 of the top 20 pharma companies to $190M+ in total contract value, and developed ConcertAI’s first multimodal real-world data product line.

ConcertAI

Science to Decisions

AI that informs drug programs, from target discovery and trial design to indication expansion.

Delivered the Data42 Knowledge Graph across Novartis R&D data and presented the analysis informing Cosentyx indication expansion in person to the Novartis CEO.

Novartis

Regulated Manufacturing & Operations

Technology for manufacturing, supply chain, and quality in regulated settings.

As functional CTO, stood up the technology for a first-of-kind radiopharmaceutical manufacturing site and built agent workflows that ran on live clinical shipments.

Nucleus RadioPharma

Platforms & Data Foundations

Cloud platforms, data architecture, and MLOps built for GxP and HIPAA.

Took AI Bench, AstraZeneca’s first GxP-compliant cloud AI platform, from behind schedule through validation and deployment, raising portfolio productivity 300%.

AstraZeneca

Innovation & IP

Scouting, build-or-buy decisions, intellectual property, and platforms that surface new ideas.

Built IDEAS, Pfizer’s global innovation platform, scaling it to ~100,000 employees in 50 countries within three months and generating 20 new portfolio assets.

Pfizer

Due Diligence & Advisory

AI and data diligence and value-creation plans for investors.

Advise private equity on AI and data opportunities across pharma, medtech, insurance, and healthcare technology, including diligence on companies and deals.

Corollary Strategy

About

I trained in bioinformatics and discovery systems, and have led AI teams in healthcare and life sciences for over 15 years. I started at Pfizer and continued through Novartis, AstraZeneca, and three companies focusing on real-world data, clinical intelligence, and radiopharmaceuticals. Through Corollary Strategy, I advise companies and investors on where AI and data can create durable competitive advantage.

EDUCATIONPh.D., Bioinformatics and Discovery Systems, Purdue University
PATENTSCo-inventor on two granted patents in AI-driven diagnostics, precision medicine, and digital health
PUBLICATIONSPeer-reviewed work on AI in respiratory medicine and digital health

Let’s talk about what comes next.

Book a 30-minute intro call, or reach me by email or LinkedIn.